Recipharm has appointed Yves Buelens to the position of General Manager for its wholly owned new subsidiary Kaysersberg Pharmaceuticals SAS.
Yves Buelens has a Master in Pharmaceutical Sciences from the University of Brussels, Belgium and a specialisation as Industrial Pharmacist (QP). He brings a broad experience to the Group acquired in various roles in the pharmaceutical industry as well as in contract manufacturing organisations in Europe. Yves has been the plant manager for the Kaysersberg facility since 2014.
Commenting on the appointment, CEO Thomas Eldered said “Yves Buelens brings valuable experience to Recipharm having worked with a variety of pharmaceutical companies including
CDMO’s. I am sure he and his team will contribute greatly to the ongoing development of Recipharm and in particular with this exciting new technology”.
Yves Buelens said “I’m looking forward to become a member of the Recipharm family. I believe it will be a fruitful environment for growth and expansion of the Kaysersberg site.
The long-term contract with Alcon will be an excellent foundation and milestone for other business opportunities and the proven quality track record will be the cornerstone to attract new customers. The Recipharm entrepreneurship combined with high technical skills of the Alsace workforce will give us a bright future together”.